Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,522 | 218 | 99.7% |
| Education | $14.08 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,111 | 82 | $0 (2023) |
| SPINAL ELEMENTS, INC. | $377.45 | 5 | $0 (2022) |
| Daiichi Sankyo Inc. | $307.46 | 28 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $306.52 | 20 | $0 (2024) |
| Nevro Corp. | $203.81 | 8 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $134.06 | 10 | $0 (2021) |
| SI-BONE, INC. | $120.87 | 7 | $0 (2023) |
| Boston Scientific Corporation | $94.48 | 5 | $0 (2021) |
| Vertical Pharmaceuticals, LLC | $84.52 | 5 | $0 (2019) |
| PFIZER INC. | $74.23 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $239.09 | 15 | Collegium Pharmaceutical, Inc. ($200.46) |
| 2023 | $125.31 | 7 | Collegium Pharmaceutical, Inc. ($64.47) |
| 2022 | $445.61 | 10 | SPINAL ELEMENTS, INC. ($377.45) |
| 2021 | $299.58 | 17 | Nevro Corp. ($70.41) |
| 2020 | $645.50 | 22 | Abbott Laboratories ($375.58) |
| 2019 | $547.31 | 25 | Abbott Laboratories ($369.95) |
| 2018 | $858.79 | 45 | Abbott Laboratories ($503.84) |
| 2017 | $1,374 | 78 | Abbott Laboratories ($822.91) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Opioid Analgesic | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Opioid Analgesic | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Opioid Analgesic | ||||||
| 09/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.54 | General |
| Category: Opioid Analgesic | ||||||
| 08/27/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/07/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Opioid Analgesic | ||||||
| 06/26/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Not Applicable | ||||||
| 06/26/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: Opioid Analgesic | ||||||
| 06/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Opioid Analgesic | ||||||
| 05/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Opioid Analgesic | ||||||
| 04/03/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: Opioid Analgesic | ||||||
| 03/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Opioid Analgesic | ||||||
| 02/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $4.57 | General |
| Category: Opioid Analgesic | ||||||
| 02/07/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.58 | General |
| Category: Opioid Analgesic | ||||||
| 01/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Opioid Analgesic | ||||||
| 12/22/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Neuromodulation | ||||||
| 12/12/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Opioid Analgesic | ||||||
| 08/29/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.99 | General |
| Category: Opioid Analgesic | ||||||
| 08/01/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| 05/02/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: Opioid Analgesic | ||||||
| 01/17/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| 12/14/2022 | SPINAL ELEMENTS, INC. | Medical Device (Device) | Food and Beverage | Cash or cash equivalent | $122.03 | General |
| Category: Orthopaedic | ||||||
| 12/14/2022 | SPINAL ELEMENTS, INC. | Medical Device (Device) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Orthopaedic | ||||||
| 11/22/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 550 | 1,025 | $1.7M | $82,078 |
| 2022 | 15 | 572 | 965 | $1.5M | $78,540 |
| 2021 | 15 | 633 | 1,233 | $1.9M | $94,629 |
| 2020 | 18 | 561 | 1,004 | $1.5M | $70,003 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 322 | $51,520 | $23,992 | 46.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 99 | 212 | $26,500 | $10,147 | 38.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 47 | 66 | $275,000 | $8,454 | 3.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 20 | 30 | $110,000 | $6,111 | 5.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 43 | 60 | $210,000 | $5,093 | 2.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 31 | 46 | $255,000 | $4,847 | 1.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 46 | 67 | $137,500 | $3,887 | 2.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 18 | 26 | $115,000 | $3,257 | 2.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 21 | 32 | $112,000 | $2,927 | 2.6% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 11 | 14 | $55,000 | $2,806 | 5.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 28 | 41 | $115,500 | $2,512 | 2.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 17 | 24 | $38,080 | $2,007 | 5.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 19 | 31 | $57,500 | $1,935 | 3.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 18 | 26 | $69,000 | $1,819 | 2.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,360 | $1,314 | 39.1% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 11 | 14 | $30,000 | $967.50 | 3.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 306 | $48,960 | $23,635 | 48.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 90 | 178 | $22,250 | $8,574 | 38.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 50 | 65 | $260,000 | $8,267 | 3.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 33 | 43 | $246,000 | $4,977 | 2.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 18 | 24 | $87,500 | $4,960 | 5.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 45 | 57 | $199,500 | $4,868 | 2.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2022 | 48 | 73 | $145,000 | $4,234 | 2.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2022 | 28 | 38 | $133,000 | $3,552 | 2.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2022 | 18 | 26 | $97,500 | $3,016 | 3.1% |
About Dr. Wayne Fleischhacker, DO
Dr. Wayne Fleischhacker, DO is a Pain Medicine healthcare provider based in Union, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386637270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Fleischhacker, DO has received a total of $4,536 in payments from pharmaceutical and medical device companies, with $239.09 received in 2024. These payments were reported across 219 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,522).
As a Medicare-enrolled provider, Fleischhacker has provided services to 2,316 Medicare beneficiaries, totaling 4,227 services with total Medicare billing of $325,249. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Union, NJ
- Active Since 08/25/2005
- Last Updated 10/06/2011
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1386637270
Products in Payments
- Proclaim Family of SCS IPGs (Device) $1,010
- SCS IPGs (Device) $868.80
- Medical Device (Device) $377.45
- Movantik (Drug) $321.61
- XTAMPZA (Drug) $279.93
- Prodigy Family of SCS IPGs (Device) $121.45
- Senza Spinal Cord Stimulation System (Device) $115.76
- LORZONE (Drug) $84.52
- Horizant (Drug) $79.20
- LYRICA (Drug) $74.23
- Algovita (Device) $70.62
- Omnia (Device) $70.41
- RELISTOR ORAL (Drug) $66.17
- SPECTRA WAVEWRITER (Device) $58.90
- DUEXIS (Drug) $58.55
- Edarbi (Drug) $54.86
- BELBUCA (Drug) $54.65
- Evzio (Drug) $53.45
- SPRIX (Drug) $50.05
- CFNS StimQ Peripheral Nerve StimulatorSystem (Device) $47.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Union
Dr. Ron Ben-Meir, D.o, D.O
Pain Medicine — Payments: $5,798
Edward Novik, M.d, M.D
Pain Medicine — Payments: $1,003
Dr. Joshua Macklin, Md, MD
Pain Medicine — Payments: $536.18
Michael Wilcenski, Md, MD
Pain Medicine — Payments: $330.48